Molecular characterisation of the residual disease after neoadjuvant endocrine therapy in ER+/HER2- breast cancer uncovers biomarkers of tumour response by Joanna I. López-Velazco, Sara Manzano, Kepa Elorriaga, Maria Otaño, Ainhara Lahuerta, Luis Álvarez, Inge Etxabe, Miren Huarte, Elvira Buch, Julia Gimenez, Vanesa Quiroga, Marta Fernandez, Sofía Aragón, Laia Paré, Aleix Prat, Isabel Álvarez-López, Maria M. Caffarel, Ander Urruticoechea

Get full text